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with protein content were significantly higher in PCA 
group than in control or sham-operated rats (duodenum 
PAG activity was 976.95±268.87 µkat/g of protein in 
PCA rats vs  429.19±126.92 µkat/g of protein in sham-
operated rats; kidneys PAG activity was 1259.18 ± 228.79 
µkat/g protein in PCA rats vs  669.67± 400.8 µkat/g of 
protein in controls, P  < 0.05; duodenal protein content: 
173% in PCA vs  sham-operated rats; in kidneys the con-
tent of protein was 152% in PCA vs  sham-operated rats). 
PAG activity and protein expression in PCA rats were 
higher in cortex and basal ganglia than those in sham-
operated rats (cortex: 6646.6 ± 1870.4 µkat/g of protein 
vs  3573.8 ± 2037.4 µkat/g of protein in control rats, 
P  < 0.01; basal ganglia, PAG activity was 3657.3 ± 1469.6 
μkat/g of protein in PCA rats vs  2271.2 ± 384 μkat/g 
of protein in sham operated rats, P  < 0.05; In the cer-
ebellum, the PAG activity was 2471.6 ± 701.4 μkat/g of 
protein vs  1452.9 ± 567.8 μkat/g of protein in the PCA 
and sham rats, respectively, P  < 0.05; content of protein: 
cerebral cortex: 162% ± 40% vs  100% ± 26%, P  < 0.009; 
and basal gangl ia: 140% ± 39% vs  100% ± 14%, 
P  < 0.05; but not in cerebel lum: 100% ± 25% vs  
100% ± 16%, P  = ns).
CONCLUSION: Increased PAG activity in kidney and 
duodenum could contribute significantly to the hyperam-
monaemia in PCA rats, animal model of encephalopathy. 
PAG is increased in non-synaptic mitochondria from the 
cortex and basal ganglia and could be implicated in the 
pathogenesis of hepatic encephalopathy. Therefore, PAG 
could be a possible target for the treatment of HE or 
liver dysfunction.
© 2006 The WJG Press. All rights reserved.
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Abstract
AIM: To assess whether portacaval anastomosis (PCA) 
in rats affects the protein expression and/or activity of 
glutaminase in kidneys, intestines and in three brain 
areas of cortex, basal ganglia and cerebellum and to 
explain the neurological alterations found in hepatic en-
cephalopathy (HE).
METHODS: Sixteen male Wistar rats weighing 250-350 
g were grouped into sham-operation control (n  = 8) or 
portacaval shunt (n  = 8). Twenty-eight days after the 
procedure, the animals were sacrificed. The duodenum, 
kidney and brain were removed, homogenised and mi-
tochondria were isolated. Ammonia was measured in 
brain and blood. Phosphate-activated glutaminase (PAG) 
activity was determined by measuring ammonia pro-
duction following incubation for one hour at 37  with 
O-phthalaldehyde (OPA) and specific activity expressed 
in units per gram of protein (µkat/g of protein). Protein 
expression was measured by immunoblotting.
RESULTS: Duodenal and kidney PAG activities together 
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INTRODUCTION
Hyperammonaemia plays a major role in the pathogenesis 
of  hepatic encephalopathy (HE). Phosphate-activated 
glutaminase (PAG) catalyzes the hydrolysis of  glutamine 
(Gln) to yield glutamate (Glu), energy, nucleotide synthesis 
and ammonia. Two main isoforms of  PAG have been 
described: the kidney-type (K-PAG) and the liver type 
(L-PAG). The K-PAG has been found in kidney, brain 
and villi enterocytes, while L-PAG is restricted to the liver. 
Hyperammonaemia is largely considered to be derived 
from urea breakdown by intestinal bacteria, thus most 
treatments have been focussed on reducing ammonia 
production from colon bacteria[1]. However, some data 
suggest that small intestine plays an important role in 
ammonia production during the pathogenesis of  hepatic 
encephalopathy
[2]
. Indeed, duodenal PAG activity has been 
found to be nearly four times higher in cirrhotic patients 
than in healthy controls, and moreover it is closely related 
to minimal hepatic encephalopathy
[3]
. In rats, the highest 
PAG activity along the length of  gastrointestinal tract has 
been measured in the small intestine
[4]
. Lower but still 
substantial activity (15% of  total PAG activity) has been 
found in large intestine. PAG activity distribution along the 
gastrointestinal tract in humans is similar to that in rats
[5]
. 
PAG plays another important role at renal level. Glutamine 
is filtered and reabsorbed in the proximal convoluted 
tubule where it is deamidated by PAG. Two thirds of  this 
ammonia production is excreted in urine. This process is 
pH sensitive and helps to maintain acid-base homeostasis 
and to excrete nitrogen
[6]
. However, PAG activity in kidney 
remains largely unexplored in portacaval shunted rats. 
Distribution and location of  PAG in brain as well as its 
role in the pathogenesis of  HE, are widely controversial, 
while PAG activity in portacaval shunted rats still remains 
unknown. Portacaval anastomosis (PCA; or portacaval 
shunt PCS) in rats is widely accepted as a model of  type 
B hepatic encephalopathy that mimics minimal hepatic 
encephalopathy in humans. The aim of  this study was 
to assess whether portacaval anastomosis in rats affects 
the expression and/or activity of  glutaminase in kidney, 
intestines and the astrocytes of  three brain areas (cortex, 
basal ganglia and cerebellum) involved in the neurological 
alterations of  hepatic encephalopathy.
MATERIALS AND METHODS
Animal surgery
Sixteen male Wistar rats (n = 16) weighing 250-350 g were 
randomly allocated into sham operation controls (n = 8) 
or portacaval shunt (n = 8). All animals were pair fed two 
weeks before and four weeks after operation and kept 
under standard laboratory conditions. Both PCA and 
sham-operated rats were fasted overnight in single wire-
net floor cages with free access to tap water. All animal 
procedures were approved by our institution and met the 
guidelines of  Spain (RD 223 erased 14th March 1998) and 
European (Directive 86/609/CEE) Union for care and 
management of  experimental animals.
Rats were operated under general anaesthesia with 
isofluorane to avoid liver metabolism of  intravenous 
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agents and end-to-side portacaval shunt was performed as 
previously described
[7]
. Briefly, after middle laparotomy for 
viscera exteriorization, inferior vena cava and portal veins 
were exposed, dissected and clamped laterally together 
with a Satinsky clamp. Longitudinal incisions in both 
veins and lateral anastomosis with running suture as usual 
were performed. Finally, portal trunk was tied and cut 
next of  liver hilum, turning the portacaval lateral shunt 
in functionally terminal. Sham-operation was performed 
following laparotomy, the inferior vena cava was isolated 
and clamped for 30 s. Sham-operated animals served as 
controls.
Determination of ammonia in brain and blood
Ammonia was measured in cerebral cortex and blood as 
previously described
[8]
. Cerebral cortex was homogenized 
and deproteinised in 5 volumes of  ice-cold 100 g/L 
trichloroacetic acid, and kept on ice for 15 min. After 
centrifugation at 12 000 r/min for 10 min at 4 , the 
supernatants were collected, neutralized with 2 mol/L 
KHCO3 and centrifuged at 12 000 r/min for 10 min at 
4 . The neutralized supernatants were used to measure 
ammonia in µmole/g tissue. Blood (150 µL) was taken 
from the tail vein the third week after surgery. Blood 
samples were deproteinized with one volume of  ice-cold 
100 g/L trichloroacetic acid and kept on ice for 15 min. 
After centrifugation at 12 000 r/min for 10 min at 4 , 
the supernatants were collected, neutralized with 2 mol/L 
KHCO3 and centrifuged at 12 000r/min for 10 min at 
4 . The neutralized supernatants were used to measure 
ammonia. In a final volume of  100 µL, the reaction mix-
ture contained 50 µL or 60 µL of  sample, 30 mmol/L 
α-ketoglutarate, 0.5 mmol/L nicotinamide adenine dinu-
cleotide (reduced form) in potassium phosphate buffer (pH 
8.0). After recording of  the initial fluorescence, reactions 
were started by the addition of  5 µg of  glutamate dehydro-
genase (Boehringer Mannheim, Germany) and monitored 
by the fluorimeter (Fluoroskan Ascent; Labsystems; Oy, 
Helsinki, Finland) for at least 70 min. Standards containing 
up to 25 nmol of  ammonia were included in each assay. 
Assays were performed in Costar 96-well UV plates (cat. 
No. 3635; Corning Costar Corporation, Cambridge, MA).
Animal handling and brain tissue preparation
All procedures were carried out in the cold room at 
2 - 4 . The rats were killed by cervical dislocation. 
The skull of  each rat was opened to remove blood from 
the surface of  the tissue and this procedure needed to 
be performed in <30 s. The tissue was placed in 5 mL 
of  isolation medium in a Petri dish maintained in an ice 
bath. The brain was chopped with fine scissors and the 
chopped material was washed frequently with isolation 
medium to remove blood. Meanwhile, the first portion of  
small intestine (3 cm of  length) was removed and placed 
in 5 mL of  isolation medium in Petri dish maintained in 
an ice bath. The duodenum was washed and mucosa was 
removed by glass film and quickly frozen in liquid air. 
Samples of  kidney were similarly obtained. Tissue samples 
were then homogenized manually in 1 mL of  isolation 
medium per 100-150 mg of  tissue using a Dounce 
www.wjgnet.com
homogenizer fitted with a Teflon pestle having a total 
clearance of  0.1 mm. Usually, six up- and down-strokes 
were sufficient to generate a rough homogenate which was 
then diluted with isolation medium to a final volume of  
1.2 mL and homogenized further with four up- and down-
strokes.
Preparation of mitochondria
The procedure for isolation of  brain mitochondria was 
based on previously reported methods
[9]
 except for 
1 mmol/L ethylene glycol-bis (β-aminoethyl ether) tetra-
acetic acid (EGTA) being used in the homogenisation 
medium instead of  EDTA. The homogenate was 
centrifuged at 2 000 r/min for 3 min, the pellet was 
washed with 400 μL of  homogenisation medium and re-
centrifuged at 2 000 r/min for 3 min. Both supernatants 
were pooled and centrifuged for 8 min at 12 000 r/min 
to obtain the crude mitochondrial pellet. The pellet was 
suspended in 300 μL of  the 30 g/L Ficoll medium (see 
below) and layered onto 1.2 mL of  60 g/L Ficoll medium 
and centrifuged at 12 000 r/min for 30 min. The 60 g/L 
Ficoll medium contained 6% (w/w) Ficoll, 0.24 mol/L 
mannitol, 0.06 mol/L sucrose, 0.05 mmol/L K-EDTA 
and 10 mmol/L Tris-HCl, pH 7.4. The 30 g/L Ficoll 
medium was the 60 g/L Ficoll medium diluted 1 : 1 with 
glass re-distilled water. The loose, fluffy, white upper layer 
of  the pellet was removed, the remaining brown pellet 
was re-suspended in isolation medium without EGTA and 
the suspension was centrifuged at 12 000 r/min for 10 
min. The pellet was re-suspended in incubation medium 
(isolation medium with 2.5 mL/L buffer containing 
protease inhibitor, 7 g/L Triton X-100, 5 mmol/L 
β-mercapto-ethanol) to obtain a protein concentration in 
the range of  5-10 g/L. After incubation on a mixing wheel 
for 30 min at 4 , the samples were frozen at -80   for 
batched activity measurement.
PAG activity assay
Mitochondrial protein was measured by the method 
of  Bradford et al
[10]
 with bovine serum albumin (BSA) 
as standard. Briefly, 25 μL of  mitochondrial solution 
was added to 35 μL of  reaction medium (150 mmol/L 
K2HPO4, pH 8; 171 mmol/L L- GLn; 1 mmol/L NH4Cl; 
pH 8). After incubation for 60 min the reaction was 
stopped with 10 μL of  100 g/L trichloroacetic acid 
(TCA). Blanks were prepared separately following the 
incubation of  the reaction medium and samples were 
mixed before the addition of  TCA. When the sample-
mixture reaction was stopped, the reaction mixture was 
placed in ice for 15 min and then centrifuged at 12 000 
r/min for 5 min at 4 . The micro-titre plate was loaded 
with 5 μL of  supernatant and 150 μL of  OPA reagent (0.2 
mol/L K2HPO4, pH 7.4; 56 mL/L ethanol; 10 mmol/L 
O-phthaldialdehyde; 0.4 mmol/L β-mercapto-ethanol). The 
plate was incubated in dark at room temperature for 45 
min. Standards of  NH4Cl were prepared to concentrations 
of  50-300 mg/L. Absorbance was measured at 405 nm 
with a spectrophotometer (R&D System, Palo Alto, 
USA). Specific activities of  enzymes were expressed in 
international units per gram (μkat/mg) of  mitochondrial 
homogenate protein.
Analysis of glutaminase protein content by immunoblotting
Samples from sham-operated rats or rats with PCS were 
homogenized in medium containing 66 mmol/L Tris-
HCl (pH 7.4), 10 g/L SDS, 1 mmol/L EGTA, 100 
ml/L glycerol, 1 mmol/L sodium orthovanadate and 1 
mmol/L sodium fluoride and the protein concentration 
was determined by the bicinchonic acid method (Pierce, 
Rockford, IL, USA). Samples were subjected to gel 
electrophoresis and immunoblotting as previously 
described
[11]
 using isoform-specific polyclonal antibodies 
raised in rabbits against K- glutaminase proteins diluted at 
1 : 1000. After incubation with anti-rabbit IgG conjugated 
with alkal ine phosphatase (Sigma, Germany) and 
development with alkaline phosphatase colour developer 
(Sigma, Germany), the image was captured using the Gel 
Printer Plus System (TDI, Madrid, Spain) and the densities 
of  the spots were measured using the Intelligent Quantifier
™ software Version 2.5.0 (BioImage
®
, Madrid, Spain). 
Results were relativized to the optical density respect to 
controls.
Statistical analysis 
Data were expressed as mean ± SD. Statistical analyses 
were performed using the SPSS 11.0 software (spss, Chi-
cago, IL). Differences in glutaminase activity or protein 
content were analysed by Student t-test. P 0.05 was 
considered statistically significant for all tests applied.
RESULTS
Ammonia measurement
Ammonia was significantly higher in PCA group than in 
control rats. Plasma ammonia level was 166 ± 51 µmol/L 
in PCA rats and 83 ± 12 µmol/L in control rats (P < 0.05). 
In the cortex, brain ammonia was 0.9±0.4 µmol/g of  
tissue in PCA rats and 0.3 ± 0.1 µmol/g of  tissue in sham 
operated rats (P < 0.05).
PAG activity in duodenum and kidneys
Duodenal and kidney PAG activities were significantly 
higher in PCA group than in control rats. In the 
duodenum, PAG activity was 976.95 ± 268.87 μkat/g of  
protein in PCA rats and 429.19 ± 126.92 μkat/g of  protein 
in sham-operated rats (P < 0.05). In mitochondria from 
kidneys, PAG activity was 1259.18 ± 228.79 μkat/g protein 
in PCA rats and 669.67 ± 400.8 μkat/g of  protein in 
controls (P < 0.05).
Glutaminase protein content in intestine and kidneys
There was a significant effect of  PCA on PAG protein 
in duodenum. The content of  protein was 173% in PCA 
compared to sham-operated rats and in kidneys the con-
tent of  protein was 152% in PCA compared to sham-
operated rats (Figure 1).
PAG activity in brain
The PAG activity was 6646.6 ± 1870.4 μkat/g of  protein 
in the cortex of  PCA rats and 3573.8 ± 2037.4 μkat/g of  
protein in that of  control rats (P < 0.01). The PAG activity 
was 3657.3 ± 1469.6 μkat/g of  protein in basal ganglia 
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of  PCA rats and 2271.2 ± 384 μkat/g of  protein in that 
of  sham-operated rats (P < 0.05). In the cerebellum, the 
PAG activity was 2471.6 ± 701.4 μkat/g of  protein and 
1452.9 ± 567.8 μkat/g of  protein in the PCA and sham-
operated rats, respectively (P < 0.05). In PCA rats, the 
PAG activity was increased up to 186% in cortex, 161% in 
basal ganglia and 170% in cerebellum compared to sham-
operated rats. The highest activity was found in the cortex 
(Figure 2).
Glutaminase protein content in cerebral cortex and basal 
ganglia
The content of  glutaminase was significantly increased in 
cerebral cortex of  PCA rats compared to sham-operated 
animals (162% ± 40% and 100% ± 26%; P < 0.009) and 
the content of  glutaminase was significantly higher in basal 
ganglia of  PCA rats than in that of  sham-operated animals 
(140% ± 39% and 100%±14%; P < 0.024), but there was 
no significant difference between the groups after PCA in 
cerebellum (100% ± 25% and 100% ± 16%; P = NS) (Figure 
3).
DISCUSSION
The PCA performed in rats is widely accepted as a model 
of  liver dysfunction. In this study, PAG activity was 
increased in kidney and duodenum, which could contribute 
significantly to systemic hyperammonaemia. PAG activity 
was increased in cortex and basal ganglia, which might 
be responsible for brain hyperammonemia and intra-
mitochondrial ammonia levels derived from glutamine 
hydrolysis that are maintained because successful 
detoxification by glutamine-synthetase is precluded. 
During the 2
nd
 half  of  the 20
th
 century, hyperam-
monaemia was considered to be derived from urea 
breakdown by intestinal bacteria and the majority of  
treatments are targeted against bacteria-derived ammonia 
from the colon
[1]
. However, the hypothesis was not 
universally accepted
[12]
. Hyperammonaemia following 
portacaval shunting in rats has been found to be similar 
in germ-free as well as in non-germ-free animals 
[13, 14]
, 
providing support to the concept that hyperammonaemia 
and encephalopathy could develop without participation 
of  bacteria
[15]
. The highest hyperammonaemia has been 
found in portal-drained viscera and derived mainly from 
glutamine deamidation
[16]
. Hence, increased PAG activity 
in small intestine could explain these observations at least 
in part. Moreover, increased PAG in duodenum has been 




Recently, renal ammoniagenesis has been implicated 
in several forms of  hepatic encephalopathy. In patients 
suffering from hepatic encephalopathy due to variceal 
bleeding or overdose of  diuretics, ammonia production 
from kidney seems to be the main factor involved in the 
development of  hepatic encephalopathy
[17]
. Glutamine 
is filtered in the glomeruli and enters the lumen of  the 
nephron. The filtered glutamine is reabsorbed in the 
proximal tubule where glutamine is deamidated by PAG. 
The main factor in the regulation of  kidney PAG activity 
seems to be pH. During metabolic acidosis, PAG activity 
increases which induces higher excretion of  ammonia
[18]
. 
In hepatic encephalopathy, metabolic alkalosis is observed 
more frequently than acidosis and increased PAG activity 
in kidney could be a protective mechanism. This PAG 
increase could be even more protective than the event 
associated with the systemic hyperammonaemia. However, 
this possibility needs to be explored in greater detail in 
future studies. 







Figure 1 Representative immunoblotting from duodenum (A) and kidneys (B). 
Glutaminase content in enterocytes from rats with portacaval shunt (PCA) and 
6 control rats (sham) homogenised and subjected to immunoblotting, 10 µg of 

































Figure 2 PAG activity (kat/g of protein) in duodenum, kidneys and brain of PCA 







Figure 3 Glutaminase content in cerebral 
cortex and basal ganglia. Cerebral cortex 
basal ganglia or cerebellum from 7 rats 
with portacaval shunt (P) and 6 control 
rats (C) was homogenised and subjected 
to immunoblotting, 10 µg of protein was 
applied in each lane. The codes under the 
bands of representative blots indicate the 
different rats with portacaval shunt (P) or 
control rats (C).
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glutamine only in astrocytes due to the predominance 
of  glutamine synthetase in these cells. Glutamine 
accumulation as a by-product of  ammonia metabolism 
has been implicated in the pathogenesis of  hepatic 
encephalopathy
[19]
. Glutamine is an osmotic amino acid 
and plays a major role in the regulation of  cell volume. 
A raised peak of  glutamine-glutamate/creatine ratio is a 
typical feature of  brain spectroscopic magnetic resonance 
imaging in hepatic encephalopathy. However, glutamine 
synthetase has not been found to be increased in brain of  
portacaval shunted rats
[20]
. Indeed, administration of  amino 
acid mixtures induces hyperammonaemia, raises glutamine 
peak in the brain and is associated with impairment in 
neuropsychological function
[21]
. Also, use of  methionine-
sulfoxamine blocks the activity of  glutamine synthetase 
and improves abnormalities induced by ammonia, 
such as seizures or astrocytes swelling
[22]
. Nevertheless, 
accumulation of  glutamine following treatment with drugs 
that are able to block N-methyl-D-aspartate (NMDA)-
receptors has not been shown to be associated with 
neurological impairment
[23]
. Indeed, in astrocyte culture, 
glutamine metabolism is linked to free radical production 
and oxidative stress and this may represent a key 
mechanism in ammonia neurotoxicity 
[24]
. Thus, glutamine 
accumulation in the brain is neither a pathological event per 
se nor a safe ammonia detoxification pathway. Glutamine 
accumulating in the astrocytes can be considered as 
a “Trojan horse” leading circuitously to neurological 
impairment. In cultured astrocytes, glutaminase inhibitors 
such as 6-diazo-5-oxo-L-norleucine (DON) induce a 
complete blockade of  glutaminase activity and preempt 
free radical production and neurotoxicity induced by 
ammonia
[25]
. Most of  the glutamine in astrocytes is 
metabolized by mitochondrial PAG
[26]
. Since ammonia 
induces free radical production, the PAG can be implicated 
in free radical production. The inhibition of  this enzyme 
could be a new therapeutic target. However, DON has also 
been reported to inhibit γ-glutamyl-transpeptidase, increase 
glutamine release, inhibit transport of  glutamine into cells 
and block the transport of  glutamine into mitochondria. 
All these mechanisms could induce a decrease in the 
amount of  glutamine available for hydrolysis
[27]
. The 
distribution of  K-type PAG in the brain has been strongly 
debated. Some studies have reported that PAG is absent 
in astrocytes of  cerebellum
[28]
. In the current study, PAG 
activity in non-synaptic mitochondria from the cerebellum 
showed the lowest activity in the brain and no differences 
were observed between PCA and sham-operated rats 
using immunoblotting. Thus, PAG could be detected in 
cerebellum, but at a low-level in comparison to other areas 
such as basal ganglia or cortex.
In summary, PAG is enhanced in the intestine and 
kidney of  PCA rats and induces  hyperammonaemia and 
hepatic encephalopathy. Furthermore, PAG activity and 
glutaminase content are increased in astrocytes from cortex 
and basal ganglia. Mitochondrial glutaminase activity 
in astrocytes could be implicated in the production of  
ammonia. The induction of  the mitochondrial permeability 
transition and free radicals production as the end product 
of  glutamine metabolism could be responsible at least 
in part for the pathogenic effect observed in hepatic 
encephalopathy. Hence, PAG might be a new therapeutic 
target in the management of  hepatic encephalopathy. 
Further studies using PAG inhibitors or PAG knock-out 
mice help clarify the role of  increased PAG expression in 
the pathophysiology of  hepatic encephalopathy.
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